Ziprasidone

What is Ziprasidone?

Ziprasidone is an atypical antipsychotic medication that belongs to the class of second-generation antipsychotics. It is primarily prescribed to treat schizophrenia and bipolar disorder by helping to restore the balance of certain neurotransmitters in the brain. The medication is available in both oral capsule form for maintenance therapy and as an injectable formulation for acute treatment.

Uses

• Schizophrenia: Used for both acute treatment of psychotic episodes and long-term maintenance therapy to prevent symptom relapse
• Bipolar I disorder: Treats acute manic or mixed episodes, often used as part of a comprehensive treatment plan
• Bipolar maintenance therapy: Helps prevent mood episodes when used as an adjunct to lithium or valproate
• Acute agitation: Injectable form provides rapid control of agitation in patients with schizophrenia or bipolar disorder
• Off-label uses: Sometimes prescribed for treatment-resistant depression as an add-on therapy, though this requires careful monitoring

How it works

Ziprasidone works by blocking certain receptors in the brain, particularly dopamine D2 receptors and serotonin 5-HT2A receptors. This dual mechanism helps reduce psychotic symptoms like hallucinations and delusions while also improving mood symptoms. Unlike older antipsychotics, ziprasidone’s balanced receptor profile typically causes fewer movement-related side effects and less weight gain.

Side effects

Common side effects:

• Drowsiness and fatigue
• Nausea and digestive upset
• Dizziness and lightheadedness
• Headache
• Restlessness or anxiety
• Constipation
• Muscle stiffness or tremor
• Sleep disturbances

Serious side effects requiring immediate medical attention:

Submit Your Paper

• Heart rhythm abnormalities (QT prolongation)
• Neuroleptic malignant syndrome (high fever, muscle rigidity, confusion)
• Tardive dyskinesia (involuntary movements of face and body)
• Severe allergic reactions
• Suicidal thoughts, especially in young adults

Warnings and precautions

• Heart conditions: Should be avoided in patients with known heart rhythm disorders or those taking medications that affect heart rhythm, as ziprasidone can prolong the QT interval
• Elderly patients with dementia: Increased risk of death when used to treat behavioral symptoms of dementia; not approved for this use
• Pregnancy and breastfeeding: Use only when potential benefits outweigh risks; can cause withdrawal symptoms in newborns when used during third trimester
• Blood sugar monitoring: May increase blood glucose levels and risk of diabetes, requiring regular monitoring in susceptible patients
• Kidney and liver function: Dose adjustments may be necessary in patients with severe kidney or liver impairment

Interactions

• Heart rhythm medications: Drugs like quinidine, amiodarone, and sotalol can increase risk of dangerous heart rhythm changes when combined with ziprasidone
• Antibiotics: Certain antibiotics like erythromycin and clarithromycin may increase ziprasidone levels and heart rhythm risks
• Antifungal medications: Ketoconazole and itraconazole can significantly increase ziprasidone blood levels
• Seizure medications: Carbamazepine may reduce ziprasidone effectiveness by increasing its breakdown in the liver
• Blood pressure medications: May enhance blood pressure-lowering effects, potentially causing dizziness or fainting
• Alcohol and sedatives: Can increase drowsiness and impair coordination and judgment
• St. John’s Wort: This herbal supplement may reduce ziprasidone levels and decrease its effectiveness
• Grapefruit juice: May increase ziprasidone levels, though the clinical significance is unclear

Check interactions with the GMJ Interaction Checker

Dosage

For schizophrenia, the typical starting dose is 20 mg twice daily with food, which may be gradually increased to 40-80 mg twice daily based on response and tolerability. For bipolar disorder, dosing usually begins at 40 mg twice daily with food, with possible increases to 60-80 mg twice daily. The injectable form is typically given as 10-20 mg intramuscularly, with a maximum of 40 mg daily. All dosing must be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and other health factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).